Your browser doesn't support javascript.
loading
Effects of carvedilol as third-line add-on therapy on blood pressure and glucose metabolism in type 2 diabetic patients with chronic renal disease stage 3 and above.
Yasuda, Gen; Yatsu, Keisuke; Yamamoto, Yuichiro; Hirawa, Nobuhito.
Affiliation
  • Yasuda G; Division of Nephrology and Hypertension, Center Hospital, Yokohama City University School of Medicine, Yokohama, Japan. y911429@yokohama-cu.ac.jp
Kidney Blood Press Res ; 36(1): 131-8, 2012.
Article in En | MEDLINE | ID: mdl-23095799
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Propanolamines / Blood Glucose / Blood Pressure / Carbazoles / Calcium Channel Blockers / Adrenergic beta-Antagonists / Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic / Angiotensin Receptor Antagonists Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Kidney Blood Press Res Journal subject: NEFROLOGIA Year: 2012 Document type: Article Affiliation country: Japón Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Propanolamines / Blood Glucose / Blood Pressure / Carbazoles / Calcium Channel Blockers / Adrenergic beta-Antagonists / Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic / Angiotensin Receptor Antagonists Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Kidney Blood Press Res Journal subject: NEFROLOGIA Year: 2012 Document type: Article Affiliation country: Japón Country of publication: Suiza